(2021)
Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes.
Adv Sci (Weinh) 8(16),
e2100536.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Leitung +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Forschungsschwerpunkte
- Medizinische & Umweltmetagenomik: Mensch, Maus, Pflanzen, marine Lebewesen
- Systembiologie: Integration von –omics-Daten; Molekül/ Protein & Protein/ Protein Netzwerke
- Synthetische Biologie: Metabolische Modellierung auf Genomausmaß, Design von Probiotika, Entdeckung von Postbiotika
Publikationen
(2020)
Effects of agricultural fungicide use on Aspergillus fumigatus abundance, antifungal susceptibility, and population structure.
mBio 11(6),
e02213-20.
(2020)
Dynamic surface proteomes of allergenic fungal conidia.
J Proteome Res 19(5),
2092-2104.
(2020)
Novel approaches for systems biology of metabolism-oriented pathogen-human interactions: A mini-review
Front Cell Infect Microbiol 10,
52.
(Review)
(2020)
Comparative transcriptomic analysis of rhinovirus and influenza virus infection.
Front Microbiol 11(1580),
1-13.
(2020)
Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A orruxolitinib: Clinicohematologic responses, quality-of-life changes and safety in the real-world setting.
Hematology 25(1),
247-257.
(2020)
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.
Cancer Med 9(10),
3371-3382.
(2020)
Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight loss.
Microbiome 8(1),
13.
(2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota.
Microbiome 8(1),
28.
(2020)
Lipid metabolic signatures deviate in sepsis survivors compared to non-survivors.
Comput Struct Biotechnol J 18,
3678-3691.